Cargando…
Prostate cancer biomarkers and multiparametric MRI: is there a role for both in prostate cancer management?
Several advancements have been made in recent years with regards to the detection and evaluation of prostate cancer (PCa). The low specificity of prostate specific antigen (PSA) has left much to be desired in a test, but a boom in novel biomarkers has made screening and surveillance more complicated...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934039/ https://www.ncbi.nlm.nih.gov/pubmed/33737957 http://dx.doi.org/10.1177/1756287221997186 |